Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors
Experiences with new multikinase inhibitors are limited, especially in children. In this report we summarize our experience with 2 patients with relapsed acute myeloblastic leukemia (AML), one with FMS-like tyrosine kinase- 3-internal tandem duplication mutation and the other with a single base muta...
Main Authors: | Deniz Yılmaz Karapınar, Nihal Karadaş, Zühal Önder Siviş, Can Balkan, Kaan Kavaklı, Yeşim Aydınok |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-07-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-57984 |
Similar Items
-
FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia
by: Mariko Takenokuchi, et al.
Published: (2012-10-01) -
Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants
by: Daseul Im, et al.
Published: (2022-12-01) -
FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
by: Hind Dehbi, et al.
Published: (2013-01-01) -
Surveying Mutation of FLT3 Genes in Children with Acute Leukemia
by: Maryam Sheikhi, et al.
Published: (2017-02-01) -
Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia
by: Natsuki Hirose, et al.
Published: (2023-12-01)